MANUEL COLON
Prescription History 1982353652
Ophthalmology in San Francisco, CA

Active since March 21, 2022PECOS Enrolled
490 ILLINOIS ST FL 5, SAN FRANCISCO, CA 94158(415) 353-2020 Get Directions

NPPES record last updated: June 29, 2026. Verified against the NPPES registry weekly; last sync: October 25, 2026.

Record update history: Jun 4, 2026, May 24, 2026 (2 updates tracked since 2026).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MANUEL COLON, an active Ophthalmology specialist practicing in San Francisco, CA. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 175 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 61 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

6
Medications
175
Total Claims
284
30-Day Fills
Latanoprost
Most Prescribed · 61 claims
View details
6 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by MANUEL COLON in 2024, with prescription volumes, average cost per fill, and CA state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other CA PrescribersVs. CA Avg

About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾

It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.

In 2024, this provider wrote 61 Medicare prescriptions for Latanoprost, about a third of the volume of the typical California prescriber of this medication (158.8). Medicare paid an average of $12.15 per fill, versus $12.02 statewide.

How often this provider prescribes it

This provider
61
CA average
158.8

This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$12.15
CA average
$12.02

Gross Part D cost per fill; not the patient's out-of-pocket price.

110.3
30-Day Fills
standardized to 30-day supplies
3,143
Days of Medication
total across all patients in 2024

About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾

Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.

In 2024, this provider wrote 30 Medicare prescriptions for Prednisolone Acetate, about 19% of the volume of the typical California prescriber of this medication (154.7). Medicare paid an average of $43.66 per fill, versus $42.12 statewide.

How often this provider prescribes it

This provider
30
CA average
154.7

This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$43.66
CA average
$42.12

Gross Part D cost per fill; not the patient's out-of-pocket price.

46.8
30-Day Fills
standardized to 30-day supplies
1,192
Days of Medication
total across all patients in 2024

About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾

Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

In 2024, this provider wrote 26 Medicare prescriptions for Brimonidine Tartrate, about a third of the volume of the typical California prescriber of this medication (89.5). Medicare paid an average of $6.58 per fill, versus $42.08 statewide.

How often this provider prescribes it

This provider
26
CA average
89.5

This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$6.58
CA average
$42.08

This provider's average cost per fill is below the CA average for this medication.

38.4
30-Day Fills
standardized to 30-day supplies
1,048
Days of Medication
total across all patients in 2024

About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors.

In 2024, this provider wrote 23 Medicare prescriptions for Dorzolamide-Timolol, about 19% of the volume of the typical California prescriber of this medication (122.2). Medicare paid an average of $13.75 per fill, versus $20.06 statewide.

How often this provider prescribes it

This provider
23
CA average
122.2

This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$13.75
CA average
$20.06

This provider's average cost per fill is below the CA average for this medication.

43.3
30-Day Fills
standardized to 30-day supplies
1,300
Days of Medication
total across all patients in 2024

About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. Topically effective ocular hypotensive carbonic anhydrase inhibitor.

In 2024, this provider wrote 21 Medicare prescriptions for Dorzolamide Hcl, about a third of the volume of the typical California prescriber of this medication (50.5). Medicare paid an average of $20.18 per fill, versus $20.46 statewide.

How often this provider prescribes it

This provider
21
CA average
50.5

This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$20.18
CA average
$20.46

This provider's average cost per fill is below the CA average for this medication.

31.2
30-Day Fills
standardized to 30-day supplies
935
Days of Medication
total across all patients in 2024

About Erythromycin: This medication is used to treat certain eye infections (such as conjunctivitis). Show more ▾

It is also used to prevent certain eye infections in newborns. It belongs to a class of drugs known as macrolide antibiotics. Erythromycin works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.

In 2024, this provider wrote 14 Medicare prescriptions for Erythromycin, about a third of the volume of the typical California prescriber of this medication (49.4). Medicare paid an average of $10.55 per fill, versus $13.38 statewide.

How often this provider prescribes it

This provider
14
CA average
49.4

This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$10.55
CA average
$13.38

This provider's average cost per fill is below the CA average for this medication.

14
30-Day Fills
standardized to 30-day supplies
305
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average CA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the CA average cost per fill.

About this data. The prescription history for MANUEL COLON is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this San Francisco, CA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.